REPORT ID 14073

Global Tinea Pedis Treatment Market Size, Status and Forecast 2022

Publish Date
23-Nov-17
Pages
118
Format
Electronic (PDF)

This report studies the global Tinea Pedis Treatment market, analyzes and researches the Tinea Pedis Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    GSK
    Exeltis USA
    Promius Pharma
    Valeant
    Incyte
    Polichem
    Viamet Pharmaceuticals
    Aqua Pharmaceuticals
    Theravance Biopharma
    Bristol-Myers Squibb
    Celgene
    Hexima
    Hisamitsu Pharmaceutical
    Dermira
    NovaBiotics
    Elorac
    F. Hoffmann-La Roche
    Galderma
    Mayne Pharma
    Sanofi
    Teva Pharmaceutical

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    By Route of Administration
    By Drug Class

Market segment by Application, Tinea Pedis Treatment can be split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Drug Stores
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Tinea Pedis Treatment Market Size, Status and Forecast 2022
1 Industry Overview of Tinea Pedis Treatment
    1.1  Tinea Pedis Treatment Market Overview
        1.1.1 Tinea Pedis Treatment Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Tinea Pedis Treatment Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Tinea Pedis Treatment Market by Type
        1.3.1 By Route of Administration
        1.3.2 By Drug Class
    1.4 Tinea Pedis Treatment Market by End Users/Application
        1.4.1 Hospital Pharmacies
        1.4.2 Retail Pharmacies
        1.4.3 Online Pharmacies
        1.4.4 Drug Stores
        1.4.5 Other

2 Global Tinea Pedis Treatment Competition Analysis by Players
    2.1 Tinea Pedis Treatment Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 GSK
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Exeltis USA
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Promius Pharma
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Valeant
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Incyte
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Polichem
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Viamet Pharmaceuticals
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Aqua Pharmaceuticals
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Theravance Biopharma
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Bristol-Myers Squibb
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Tinea Pedis Treatment Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Celgene
    3.12 Hexima
    3.13 Hisamitsu Pharmaceutical
    3.14 Dermira
    3.15 NovaBiotics
    3.16 Elorac
    3.17 F. Hoffmann-La Roche
    3.18 Galderma
    3.19 Mayne Pharma
    3.20 Sanofi
    3.21 Teva Pharmaceutical

4 Global Tinea Pedis Treatment Market Size by Type and Application (2012-2017)
    4.1 Global Tinea Pedis Treatment Market Size by Type (2012-2017)
    4.2 Global Tinea Pedis Treatment Market Size by Application (2012-2017)
    4.3 Potential Application of Tinea Pedis Treatment in Future
    4.4 Top Consumer/End Users of Tinea Pedis Treatment

5 United States Tinea Pedis Treatment Development Status and Outlook
    5.1 United States Tinea Pedis Treatment Market Size (2012-2017)
    5.2 United States Tinea Pedis Treatment Market Size and Market Share by Players (2016 and 2017)

6 EU Tinea Pedis Treatment Development Status and Outlook
    6.1 EU Tinea Pedis Treatment Market Size (2012-2017)
    6.2 EU Tinea Pedis Treatment Market Size and Market Share by Players (2016 and 2017)

7 Japan Tinea Pedis Treatment Development Status and Outlook
    7.1 Japan Tinea Pedis Treatment Market Size (2012-2017)
    7.2 Japan Tinea Pedis Treatment Market Size and Market Share by Players (2016 and 2017)

8 China Tinea Pedis Treatment Development Status and Outlook
    8.1 China Tinea Pedis Treatment Market Size (2012-2017)
    8.2 China Tinea Pedis Treatment Market Size and Market Share by Players (2016 and 2017)

9 India Tinea Pedis Treatment Development Status and Outlook
    9.1 India Tinea Pedis Treatment Market Size (2012-2017)
    9.2 India Tinea Pedis Treatment Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Tinea Pedis Treatment Development Status and Outlook
    10.1 Southeast Asia Tinea Pedis Treatment Market Size (2012-2017)
    10.2 Southeast Asia Tinea Pedis Treatment Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Tinea Pedis Treatment Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Tinea Pedis Treatment Revenue and Growth Rate (2017-2022)
        11.1.2 EU Tinea Pedis Treatment Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Tinea Pedis Treatment Revenue and Growth Rate (2017-2022)
        11.1.4 China Tinea Pedis Treatment Revenue and Growth Rate (2017-2022)
        11.1.5 India Tinea Pedis Treatment Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Tinea Pedis Treatment Revenue and Growth Rate (2017-2022)
    11.2 Global Tinea Pedis Treatment Market Size (Value) by Type (2017-2022)
    11.3 Global Tinea Pedis Treatment Market Size by Application (2017-2022)

12 Tinea Pedis Treatment Market Dynamics
    12.1 Tinea Pedis Treatment Market Opportunities
    12.2 Tinea Pedis Treatment Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Tinea Pedis Treatment Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Tinea Pedis Treatment Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source